Large inguinal synovial sarcoma mimics a vascular lesion
Authors:
Open Access
- 1 January 2020
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 77 (C) , 333-336
Abstract
Introduction: Synovial sarcoma (SS) is one of soft tissue sarcomas (STS), characterized by t(X;18)(p11;q11) chromosomal translocation. Clinical diagnosis of SS in groin is difficult owing to rarity and various manifestations. We reported a rare and interesting case of inguinal biphasic SS with initial impression of a vascular lesion. Presentation of case: We reported a 72-year-old man who presented with a right inguinal progressively enlarged mass for 5 years. The mass became ulcerative with active bleeding after blunt trauma. Computed tomography (CT) showed a large heterogeneous tumor with focal vivid enhanced area, and an inguinal vascular lesion was impressed. Angiography revealed faint tumor stain without contrast extravasation or aneurysm lesion. Surgical resection of the tumor was performed. Final pathology and fluorescence in situ examination (FISH) demonstrated biphasic SS with SS18 gene rearrangement. No evidence of recurrence after one-year follow-up. Discussion: SS constitutes 5%–10% of STS. The most primary sites are extremities (68.7%) and trunk (15.7%). Treatment options for SS include surgery, chemotherapy, radiotherapy, targeted therapy, and novel therapies. In our case, the initial impressions of large inguinal tumor were hematoma or pseudoaneurysm. Preoperative angiography assisted in differentiating the lesion, evaluating tumor vessels, and preventing bleeding by embolization. Our patient recovered satisfactorily after surgical excision without major complications. Conclusion: Primary inguinal SS is an extremely rare tumor which can present as a vascular lesion. Diagnosis is confirmed by pathology and FISH exam. Further studies are required to determine the manifestation and management of SS. Highlights:Keywords
This publication has 15 references indexed in Scilit:
- Systemic Treatment for Adults with Synovial SarcomaCurrent Treatment Options in Oncology, 2018
- Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entityEuropean Journal of Cancer, 2016
- Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trialsAnnals of Oncology, 2014
- The Epidemiology of SarcomaClinical Sarcoma Research, 2012
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet, 2012
- Soft tissue sarcoma across the age spectrum: A population‐based study from the surveillance epidemiology and end results databasePediatric Blood & Cancer, 2011
- Malignant inguinal monophasic synovial sarcoma: report of a case and review of the literatureWorld Journal of Surgical Oncology, 2010
- Synovial Sarcoma Is a Stem Cell MalignancyStem Cells, 2010
- Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcomaJournal of Translational Medicine, 2005
- Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?Histopathology, 2000